205 related articles for article (PubMed ID: 21454975)
21. Pseudomonas aeruginosa-catecholamine inotrope interactions: a contributory factor in the development of ventilator-associated pneumonia?
Freestone PP; Hirst RA; Sandrini SM; Sharaff F; Fry H; Hyman S; O'Callaghan C
Chest; 2012 Nov; 142(5):1200-1210. PubMed ID: 22556319
[TBL] [Abstract][Full Text] [Related]
22. Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control.
Bjarnsholt T; Tolker-Nielsen T; Høiby N; Givskov M
Expert Rev Mol Med; 2010 Apr; 12():e11. PubMed ID: 20370936
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of ceftolozane in a murine model of Pseudomonas aeruginosa acute pneumonia: in vivo antimicrobial activity and impact on host inflammatory response.
Jacqueline C; Roquilly A; Desessard C; Boutoille D; Broquet A; Le Mabecque V; Amador G; Potel G; Caillon J; Asehnoune K
J Antimicrob Chemother; 2013 Jan; 68(1):177-83. PubMed ID: 22941899
[TBL] [Abstract][Full Text] [Related]
24. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].
Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F
Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381
[TBL] [Abstract][Full Text] [Related]
25. Lack of impact of selective digestive decontamination on Pseudomonas aeruginosa ventilator-associated pneumonia: benchmarking the evidence base.
Hurley JC
J Antimicrob Chemother; 2011 Jun; 66(6):1365-73. PubMed ID: 21429939
[TBL] [Abstract][Full Text] [Related]
26. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
Murray TS; Egan M; Kazmierczak BI
Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
[TBL] [Abstract][Full Text] [Related]
27. Autoinducer production and quorum-sensing dependent phenotypes of Pseudomonas aeruginosa vary according to isolation site during colonization of intubated patients.
Favre-Bonté S; Chamot E; Köhler T; Romand JA; van Delden C
BMC Microbiol; 2007 Apr; 7():33. PubMed ID: 17442101
[TBL] [Abstract][Full Text] [Related]
28. Joint Intratracheal Surfactant-Antibacterial Therapy in Experimental Pseudomonas-Induced Pneumonia.
Birkun AA; Kubyshkin AV; Novikov NY; Krivorutchenko YL; Fedosov MI; Postnikova ON; Snitser AA
J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):299-307. PubMed ID: 25517041
[TBL] [Abstract][Full Text] [Related]
29. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa.
van Gennip M; Moser C; Christensen LD; Bjarnsholt T; Calum H; Jensen PØ; Christophersen L; Hougen HP; Ciofu O; Molin S; Givskov M; Høiby N
J Antimicrob Chemother; 2009 Dec; 64(6):1241-50. PubMed ID: 19815632
[TBL] [Abstract][Full Text] [Related]
30. Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa.
Gelfand MS; Cleveland KO
Clin Infect Dis; 2015 Sep; 61(5):853-5. PubMed ID: 26021991
[No Abstract] [Full Text] [Related]
31. In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycin.
Martha B; Croisier D; Durand D; Hocquet D; Plesiat P; Piroth L; Portier H; Chavanet P
Clin Microbiol Infect; 2006 May; 12(5):426-32. PubMed ID: 16643518
[TBL] [Abstract][Full Text] [Related]
32. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
[TBL] [Abstract][Full Text] [Related]
33. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses.
Gellatly SL; Hancock RE
Pathog Dis; 2013 Apr; 67(3):159-73. PubMed ID: 23620179
[TBL] [Abstract][Full Text] [Related]
34. The rapid
Wang K; Chen YQ; Salido MM; Kohli GS; Kong JL; Liang HJ; Yao ZT; Xie YT; Wu HY; Cai SQ; Drautz-Moses DI; Darling AE; Schuster SC; Yang L; Ding Y
Open Biol; 2017 Sep; 7(9):. PubMed ID: 28878043
[No Abstract] [Full Text] [Related]
35. Resistance rates of Pseudomonas aeruginosa and Acinetobacter species causing ventilator-associated pneumonia do not always correlate with utilisation of antibiotics.
Jankovic S; Djordjevic Z; Matovic M
J Hosp Infect; 2011 Jan; 77(1):77-8. PubMed ID: 21122946
[No Abstract] [Full Text] [Related]
36. Ventilator-associated pneumonia caused by Pseudomonas infection.
Dunn M; Wunderink RG
Clin Chest Med; 1995 Mar; 16(1):95-109. PubMed ID: 7768096
[TBL] [Abstract][Full Text] [Related]
37. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
[TBL] [Abstract][Full Text] [Related]
38. Effect of adjunctive treatment with gamma interferon against Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
Babalola CP; Nightingale CH; Nicolau DP
Int J Antimicrob Agents; 2004 Sep; 24(3):219-25. PubMed ID: 15325424
[TBL] [Abstract][Full Text] [Related]
39. Aerosolized recombinant human lysozyme ameliorates Pseudomonas aeruginosa-induced pneumonia in hamsters.
Bhavsar T; Liu M; Hardej D; Liu X; Cantor J
Exp Lung Res; 2010 Mar; 36(2):94-100. PubMed ID: 20205599
[TBL] [Abstract][Full Text] [Related]
40. Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection.
Cirioni O; Ghiselli R; Silvestri C; Minardi D; Gabrielli E; Orlando F; Rimini M; Brescini L; Muzzonigro G; Guerrieri M; Giacometti A
J Antimicrob Chemother; 2011 Jun; 66(6):1318-23. PubMed ID: 21406436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
